Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 619

1.

Enhancement in Site-Specific Delivery of Carvacrol against Methicillin Resistant Staphylococcus aureus Induced Skin Infections Using Enzyme Responsive Nanoparticles: A Proof of Concept Study.

Mir M, Ahmed N, Permana AD, Rodgers AM, Donnelly RF, Rehman AU.

Pharmaceutics. 2019 Nov 13;11(11). pii: E606. doi: 10.3390/pharmaceutics11110606.

2.

Gut Check Time: Antibiotic Delivery Strategies to Reduce Antimicrobial Resistance.

Kelly SA, Rodgers AM, O'Brien SC, Donnelly RF, Gilmore BF.

Trends Biotechnol. 2019 Nov 19. pii: S0167-7799(19)30249-5. doi: 10.1016/j.tibtech.2019.10.008. [Epub ahead of print] Review.

PMID:
31757410
3.

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.

Molina JM, Squires K, Sax PE, Cahn P, Lombaard J, DeJesus E, Lai MT, Rodgers A, Lupinacci L, Kumar S, Sklar P, Hanna GJ, Hwang C, Martin EA; DRIVE-FORWARD trial group.

Lancet HIV. 2019 Nov 15. pii: S2352-3018(19)30336-4. doi: 10.1016/S2352-3018(19)30336-4. [Epub ahead of print]

PMID:
31740348
4.

Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysis.

Shariful Islam SM, Farmer AJ, Bobrow K, Maddison R, Whittaker R, Pfaeffli Dale LA, Lechner A, Lear S, Eapen Z, Niessen LW, Santo K, Stepien S, Redfern J, Rodgers A, Chow CK.

Open Heart. 2019 Oct 9;6(2):e001017. doi: 10.1136/openhrt-2019-001017. eCollection 2019.

5.

Mobile phone text messaging and app-based interventions for smoking cessation.

Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y, Dobson R.

Cochrane Database Syst Rev. 2019 Oct 22;10:CD006611. doi: 10.1002/14651858.CD006611.pub5. [Epub ahead of print] Review.

PMID:
31638271
6.

Does splitting a tablet obtain the accurate dose?: A systematic review protocol.

Chaudhri K, Kearney M, Di Tanna GL, Day RO, Rodgers A, Atkins ER.

Medicine (Baltimore). 2019 Oct;98(42):e17189. doi: 10.1097/MD.0000000000017189.

7.

Effect of dose administration aids on adherence to self-administered medications: a systematic review protocol.

Chaudhri K, Kearney M, Day RO, Rodgers A, Atkins E.

BMJ Open. 2019 Oct 3;9(10):e030536. doi: 10.1136/bmjopen-2019-030536.

8.

Technology update: dissolvable microneedle patches for vaccine delivery.

Rodgers AM, Cordeiro AS, Donnelly RF.

Med Devices (Auckl). 2019 Sep 19;12:379-398. doi: 10.2147/MDER.S198220. eCollection 2019.

9.

Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes.

Evangelopoulos D, Prosser GA, Rodgers A, Dagg BM, Khatri B, Ho MM, Gutierrez MG, Cortes T, de Carvalho LPS.

Nat Commun. 2019 Sep 13;10(1):4177. doi: 10.1038/s41467-019-12074-z.

10.

Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial.

Ohkuma T, Zoungas S, Jun M, Lisheng L, Mancia G, Marre M, Rodgers A, Williams B, Woodward M, Chalmers J; ADVANCE Collaborative Group.

Diabetes Obes Metab. 2019 Sep 4. doi: 10.1111/dom.13878. [Epub ahead of print]

PMID:
31486188
11.

Clinical factors associated with success in applying laparoscopy in the management of small bowel obstruction at a tertiary care center.

Denkler CS, Rodgers A, Emery EL, Collins DT, Liu C, Fennessy T, Dort JM.

Surg Endosc. 2019 Sep 3. doi: 10.1007/s00464-019-07098-x. [Epub ahead of print]

PMID:
31482347
12.
13.

Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial.

Lung T, Jan S, de Silva HA, Guggilla R, Maulik PK, Naik N, Patel A, de Silva AP, Rajapakse S, Ranasinghe G, Prabhakaran D, Rodgers A, Salam A, Selak V, Stepien S, Thom S, Webster R, Lea-Laba T; TRIUMPH Study Group.

Lancet Glob Health. 2019 Oct;7(10):e1359-e1366. doi: 10.1016/S2214-109X(19)30343-2. Epub 2019 Aug 30.

14.

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing.

Liu TT, Rodgers AC, Nicholson TM, Macoska JA, Marker PC, Vezina CM, Bjorling DE, Roldan-Alzate A, Hernando D, Lloyd GL, Hacker TA, Ricke WA.

J Vis Exp. 2019 Aug 14;(150). doi: 10.3791/59802.

PMID:
31475976
15.

High Prevalence of Diabetes Distress in a University Population.

Beverly EA, Rennie RG, Guseman EH, Rodgers A, Healy AM.

J Am Osteopath Assoc. 2019 Sep 1;119(9):556-568. doi: 10.7556/jaoa.2019.099.

PMID:
31449302
16.

The 2016 Joint European Prevention Guidelines and the uses of polypills: Time to update the evidence.

Webster R, Grobbee D, Rodgers A.

Eur J Prev Cardiol. 2019 Aug 25:2047487319872660. doi: 10.1177/2047487319872660. [Epub ahead of print] No abstract available.

PMID:
31446790
17.

Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations.

Wong A, Goldstein D, Mallolas J, DeJesus E, Johnson M, Molina JM, Pozniak A, Rodgers A, Teal V, Hepler D, Kumar S, Sklar P, Hanna GJ, Hwang C, Badshah C, Teppler H.

J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):e47-e49. doi: 10.1097/QAI.0000000000002153. No abstract available.

18.

Origins of the Flyswatter.

Soppelsa P, Rodgers AS.

Technol Cult. 2019;60(3):886-895. doi: 10.1353/tech.2019.0077. No abstract available.

PMID:
31422970
19.

Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trial.

Gatell JM, Morales-Ramirez JO, Hagins DP, Thompson M, Arastéh K, Hoffmann C, Raffi F, Osiyemi O, Dretler R, Harvey C, Xu X, Plettenberg A, Smith DE, Portilla J, Rugina S, Kumar S, Frobose C, Wan H, Rodgers A, Hwang C, Teppler H.

Antivir Ther. 2019 Jul 29. doi: 10.3851/IMP3323. [Epub ahead of print]

PMID:
31355775
20.

An essential bifunctional enzyme in Mycobacterium tuberculosis for itaconate dissimilation and leucine catabolism.

Wang H, Fedorov AA, Fedorov EV, Hunt DM, Rodgers A, Douglas HL, Garza-Garcia A, Bonanno JB, Almo SC, de Carvalho LPS.

Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15907-15913. doi: 10.1073/pnas.1906606116. Epub 2019 Jul 18.

21.

Effects of continuous positive airway pressure on depression and anxiety symptoms in patients with obstructive sleep apnoea: results from the sleep apnoea cardiovascular Endpoint randomised trial and meta-analysis.

Zheng D, Xu Y, You S, Hackett ML, Woodman RJ, Li Q, Woodward M, Loffler KA, Rodgers A, Drager LF, Lorenzi-Filho G, Wang X, Quan WW, Tripathi M, Mediano O, Ou Q, Chen R, Liu Z, Zhang X, Luo Y, McArdle N, Mukherjee S, McEvoy RD, Anderson CS.

EClinicalMedicine. 2019 Jun 13;11:89-96. doi: 10.1016/j.eclinm.2019.05.012. eCollection 2019 May-Jun.

22.

Evaluating the prevalence and quality of conference codes of conduct.

Foxx AJ, Barak RS, Lichtenberger TM, Richardson LK, Rodgers AJ, Webb Williams E.

Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):14931-14936. doi: 10.1073/pnas.1819409116. Epub 2019 Jul 8.

PMID:
31285334
23.

Rodent species as possible reservoirs of Borrelia burgdorferi in a prairie ecosystem.

Beckmann S, Freund R, Pehl H, Rodgers A, Venegas T.

Ticks Tick Borne Dis. 2019 Aug;10(5):1162-1167. doi: 10.1016/j.ttbdis.2019.06.011. Epub 2019 Jun 13.

PMID:
31248821
24.

Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States.

Gaziano TA, Pandya A, Sy S, Jardim TV, Ogden JM, Rodgers A, Weinstein MC.

Am Heart J. 2019 Aug;214:77-87. doi: 10.1016/j.ahj.2019.04.020. Epub 2019 May 7.

PMID:
31174054
25.

Does Co-administration of Antihypertensive Drugs and Statins Alter Their Efficacy and Safety? A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Kanukula R, Esam H, Sundström J, Rodgers A, Salam A.

J Cardiovasc Pharmacol. 2019 Jun;73(6):352-358. doi: 10.1097/FJC.0000000000000671.

PMID:
31162243
26.

Theoretical and laboratory investigations of the effects of hydroxyproline ingestion on the metabolic and physicochemical risk factors for calcium oxalate kidney stone formation in a small group of healthy subjects.

Rodgers A, Cele P, Ravenscroft N, Edmonds-Smith C, Jackson G.

Int Urol Nephrol. 2019 Jul;51(7):1121-1127. doi: 10.1007/s11255-019-02186-2. Epub 2019 Jun 3.

PMID:
31161522
27.

Once-Daily Doravirine in HIV-1-Infected, Antiretroviral-Naive Adults: An Integrated Efficacy Analysis.

Orkin C, Molina JM, Lombaard J, DeJesus E, Rodgers A, Kumar S, Martin E, Hanna G, Hwang C.

Clin Infect Dis. 2019 May 23. pii: ciz424. doi: 10.1093/cid/ciz424. [Epub ahead of print]

PMID:
31121015
28.

Once-Daily Doravirine for Initial Treatment of Adults Living With HIV-1: An Integrated Safety Analysis.

Thompson M, Orkin C, Molina JM, Sax P, Cahn P, Squires K, Xu X, Rodgers A, Kumar S, Teppler H, Martin E, Hanna G, Hwang C.

Clin Infect Dis. 2019 May 23. pii: ciz423. doi: 10.1093/cid/ciz423. [Epub ahead of print]

PMID:
31121013
29.

Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials.

Salam A, Atkins ER, Hsu B, Webster R, Patel A, Rodgers A.

J Hypertens. 2019 Aug;37(8):1567-1573. doi: 10.1097/HJH.0000000000002089.

PMID:
31058799
30.

HDAC Regulates Transcription at the Outset of Axolotl Tail Regeneration.

Voss SR, Ponomareva LV, Dwaraka VB, Pardue KE, Baddar NWAH, Rodgers AK, Woodcock MR, Qiu Q, Crowner A, Blichmann D, Khatri S, Thorson JS.

Sci Rep. 2019 May 1;9(1):6751. doi: 10.1038/s41598-019-43230-6.

31.

Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.

Rahman F, McEvoy JW, Ohkuma T, Marre M, Hamet P, Harrap S, Mancia G, Rodgers A, Selvin E, Williams B, Muntner P, Chalmers J, Woodward M.

Hypertension. 2019 Jun;73(6):1291-1299. doi: 10.1161/HYPERTENSIONAHA.118.12414.

PMID:
31030606
32.

Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials.

Salam A, Kanukula R, Atkins E, Wang X, Islam S, Kishore SP, Jaffe MG, Patel A, Rodgers A.

J Hypertens. 2019 Sep;37(9):1768-1774. doi: 10.1097/HJH.0000000000002096.

PMID:
30986788
33.

Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials.

Pinho-Gomes AC, Azevedo L, Bidel Z, Nazarzadeh M, Canoy D, Copland E, Salam A, Rodgers A, Kotecha D, Rahimi K.

J Hypertens. 2019 Sep;37(9):1757-1767. doi: 10.1097/HJH.0000000000002094.

PMID:
30950980
34.

Cardiovascular events with blood pressure lowering in patients with diabetes and systolic blood pressure below 140 mm Hg.

Salam A, Rodgers A.

J Clin Hypertens (Greenwich). 2019 May;21(5):689. doi: 10.1111/jch.13522. Epub 2019 Mar 24. No abstract available.

35.

Control of Klebsiella pneumoniae Infection in Mice by Using Dissolving Microarray Patches Containing Gentamicin.

Rodgers AM, McCrudden MTC, Courtenay AJ, Kearney MC, Edwards KL, Ingram RJ, Bengoechea J, Donnelly RF.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02612-18. doi: 10.1128/AAC.02612-18. Print 2019 May.

36.

Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study.

Jun M, Jardine MJ, Perkovic V, Pilard Q, Billot L, Rodgers A, Rogers K, Gallagher M.

PLoS One. 2019 Mar 7;14(3):e0213192. doi: 10.1371/journal.pone.0213192. eCollection 2019.

37.

Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial.

Shariful Islam SM, Chow CK, Redfern J, Kok C, Rådholm K, Stepien S, Rodgers A, Hackett ML.

BMJ Open. 2019 Feb 20;9(2):e022637. doi: 10.1136/bmjopen-2018-022637.

38.

A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression - the way to go? Results from a pilot randomised controlled trial.

Gálvez Ortiz V, Glue P, Somogyi AA, Martin D, Alonzo A, Rodgers A, Mitchell PB, Li A, Huggins C, Loo CK.

J Psychopharmacol. 2019 Feb;33(2):260-261. doi: 10.1177/0269881118822147. No abstract available.

PMID:
30773113
39.

Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.

Fakier S, Rodgers A, Jackson G.

Urolithiasis. 2019 Dec;47(6):493-502. doi: 10.1007/s00240-019-01117-1. Epub 2019 Feb 14.

PMID:
30767040
41.
42.

Uncertainty analysis for infrasound waveform inversion: Application to explosion yield estimation.

Kim K, Rodgers A, Wright M.

J Acoust Soc Am. 2018 Dec;144(6):3351. doi: 10.1121/1.5082549.

PMID:
30599684
43.

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.

Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.

44.

Feasibility and potential efficacy of commercial mHealth/eHealth tools for weight loss in African American breast cancer survivors: pilot randomized controlled trial.

Ferrante JM, Devine KA, Bator A, Rodgers A, Ohman-Strickland PA, Bandera EV, Hwang KO.

Transl Behav Med. 2018 Dec 9. doi: 10.1093/tbm/iby124. [Epub ahead of print]

PMID:
30535101
45.

Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.

Nachman S, Alvero C, Teppler H, Homony B, Rodgers AJ, Graham BL, Fenton T, Frenkel LM, Browning RS, Hazra R, Wiznia AA; IMPAACT 1066 study team.

Lancet HIV. 2018 Dec;5(12):e715-e722. doi: 10.1016/S2352-3018(18)30257-1.

46.

Regression to the mean of repeated ambulatory blood pressure monitoring in five studies.

Moore MN, Atkins ER, Salam A, Callisaya ML, Hare JL, Marwick TH, Nelson MR, Wright L, Sharman JE, Rodgers A.

J Hypertens. 2019 Jan;37(1):24-29. doi: 10.1097/HJH.0000000000001977.

PMID:
30499921
47.

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A; Blood Pressure Lowering Treatment Trialists’ Collaboration.

J Hypertens. 2019 Jan;37(1):16-23. doi: 10.1097/HJH.0000000000001994.

PMID:
30499920
48.

Novel Hydrogel-Forming Microneedle Array for Intradermal Vaccination in Mice Using Ovalbumin as a Model Protein Antigen.

Courtenay AJ, Rodgers AM, McCrudden MTC, McCarthy HO, Donnelly RF.

Mol Pharm. 2019 Jan 7;16(1):118-127. doi: 10.1021/acs.molpharmaceut.8b00895. Epub 2018 Nov 27.

PMID:
30452868
49.

Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India.

Praveen D, Peiris D, MacMahon S, Mogulluru K, Raghu A, Rodgers A, Chilappagari S, Prabhakaran D, Clifford GD, Maulik PK, Atkins E, Joshi R, Heritier S, Jan S, Patel A.

BMC Public Health. 2018 Nov 15;18(1):1264. doi: 10.1186/s12889-018-6142-x.

50.

Report of the proceedings of a UK skin safety advisory group.

Browning P, Beeckman D, White R, Connolly R, Rodgers A, Maclean G, Fumarola S, Harker J, Murray V, Foster S.

Br J Nurs. 2018 Nov 8;27(20):S34-S40. doi: 10.12968/bjon.2018.27.Sup20.S34.

PMID:
30418847

Supplemental Content

Loading ...
Support Center